Home › Craig Hallum Reiterates Buy Rating for Ligand Pharmaceuticals
 

Keywords :   


Craig Hallum Reiterates Buy Rating for Ligand Pharmaceuticals

2015-05-24 10:58:48| Biotech - Topix.net

's stock had its "buy" rating restated by investment analysts at Craig Hallum in a note issued to investors on Saturday. They currently have a $105.00 target price on the biotechnology company's stock, up from their previous target price of $90.00.

Tags: buy rating craig pharmaceuticals

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.10Eastern North Pacific Tropical Weather Outlook
05.10Atlantic Tropical Weather Outlook
04.10Should you tip even if the service wasn't worth it?
04.10Hurricane Kirk Graphics
04.10Hurricane Kirk Forecast Discussion Number 22
04.10Tropical Storm Leslie Forecast Discussion Number 10
04.10Hurricane Kirk Wind Speed Probabilities Number 22
04.10Hurricane Kirk Public Advisory Number 22
More »